(Q37254243)

English

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (C

scientific article published on 30 July 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (C (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1 reference

based on heuristic

inferred from title

9

object named as

David Hurd

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

author name string

Asad Bashey

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Kouros Owzar

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Jeffrey L Johnson

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Peggy S Edwards

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Michael Kelly

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Lee-Ann Baxter-Lowe

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Steven Devine

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sherif Farag

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Edward Ball

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Philip McCarthy

11

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

John Lister

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Thomas C Shea

13

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Charles Linker

14

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

30 July 2010

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

17

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

558-565

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807877

28 September 2017

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807877

26 June 2018

Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807877

3 September 2018

Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807877

3 September 2018

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807877

3 September 2018

Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807877

3 September 2018

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807877

3 September 2018

Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second allogeneic transplantation after failure of first autologous transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the F

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20674758

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2010.07.015

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37254243&oldid=1782267382"